1|Page
NUR 210 EXAMS 1–4 GALEN
PHARMACOLOGY (2026) [QUESTION 1–
100] AND ANSWERS UPDATED 2026/2027 |
DETAILED RATIONALES – PRACTICE
EXAM REVIEW | INSTANT STUDY
GUIDE
Introduction
NUR 210 Pharmacology Exams 1–4 practice bank is designed to help nursing students
strengthen their understanding of pharmacological principles, medication safety, drug
classifications, therapeutic effects, adverse reactions, and clinical decision-making. It is intended
for students preparing for pharmacology assessments in a nursing program, including students
reviewing material associated with Galen College of Nursing.
Pharmacology requires more than memorizing medication names. Students must understand how
medications work, recognize potentially dangerous reactions, interpret patient assessment
findings, identify contraindications, and determine appropriate nursing interventions. These skills
are essential for safe medication administration and effective patient care.
This practice bank uses four-option multiple-choice questions, clinical scenarios, and detailed
rationales. The questions emphasize application and prioritization, including medication
calculations, pharmacokinetics, cardiovascular medications, antibiotics, endocrine drugs, and
other commonly studied medication groups. Each rationale explains the reasoning behind the
correct answer and why the alternatives are less appropriate.
Use this resource alongside your course notes, assigned textbook, and instructor-provided
objectives. The questions are original study exercises, not verified copies of Galen examination
questions, and the precise content of individual exams may vary. Consistent practice, review of
mistakes, and understanding the underlying principles can help you prepare more confidently.
Content area overview
The following is a suggested study framework for a four-exam introductory nursing
pharmacology course. Exact course coverage and question weights may differ.
1
Pharmacological foundations and medication safety
,2|Page
Suggested questions: 1–25 · Weight: 25%
Pharmacokinetics, pharmacodynamics, dosage calculations, routes, medication administration,
interactions, and safety principles.
2
Cardiovascular and renal pharmacology
Suggested questions: 26–45 · Weight: 20%
Antihypertensives, diuretics, heart failure medications, anticoagulants, and electrolyte
monitoring.
3
Anti-infective, respiratory, and immune medications
Suggested questions: 46–65 · Weight: 20%
Antibiotics, antimicrobial resistance, allergy reactions, bronchodilators, corticosteroids, and
patient education.
4
Endocrine, neurological, pain, and gastrointestinal medications
Suggested questions: 66–85 · Weight: 20%
Insulin, thyroid medications, analgesics, sedatives, seizure medications, and gastrointestinal
therapies.
5
Clinical judgment and integrated medication management
Suggested questions: 86–100 · Weight: 15%
High-alert medications, adverse reactions, prioritization, monitoring, patient teaching, and
evaluation of therapeutic outcomes.
QUESTIONS 1–100
,3|Page
Section 1: Pharmacological Foundations and Medication
Safety
Q1: A nurse administers an oral medication to a patient with significant hepatic
impairment. The medication normally undergoes extensive first-pass
metabolism. Which outcome should the nurse anticipate?
A) The medication will be completely eliminated through the lungs.
B) The medication's bioavailability may increase, potentially increasing its effects and toxicity.
C) The medication will become inactive before reaching the systemic circulation.
D) The medication will always require a higher dose to achieve a therapeutic effect.
Rationale: B is correct because impaired hepatic metabolism can reduce first-pass elimination,
allowing a greater proportion of an oral dose to reach systemic circulation. A is incorrect because
pulmonary elimination is not implied by hepatic impairment. C is incorrect because reduced
first-pass metabolism may increase, rather than eliminate, systemic drug exposure. D is incorrect
because an increased dose could worsen toxicity; dose adjustments depend on the medication,
severity of impairment, and clinical evidence.
Q2: A patient receiving a medication with a narrow therapeutic index develops
signs of toxicity despite receiving the prescribed dose. Which nursing action is
most appropriate?
A) Administer the next dose early to stabilize the drug concentration.
B) Double the next dose if the therapeutic effect is inadequate.
C) Assess the patient, review relevant laboratory results and drug levels when indicated, and
promptly notify the prescriber.
D) Independently discontinue all the patient's medications permanently.
Rationale: C is correct because a narrow therapeutic index means the difference between
therapeutic and toxic concentrations is small. Assessment, medication reconciliation, and
indicated monitoring support timely intervention. A and B can increase drug exposure and
worsen toxicity. D exceeds the usual scope of independent nursing medication management and
could cause harm; urgent withholding or discontinuation should follow applicable protocols and
clinical orders.
, 4|Page
Q3: A patient taking a medication that is highly bound to plasma proteins begins
a second medication that competes for protein-binding sites. Which statement
best describes a possible consequence?
A) The first medication must immediately be excreted unchanged.
B) Protein binding always prevents drug interactions.
C) The first medication becomes permanently inactive.
D) The unbound fraction of the first medication may temporarily increase, potentially increasing
its pharmacological effects or toxicity.
Rationale: D is correct because displacement from protein-binding sites can increase the
unbound drug fraction. The clinical effect depends on distribution, clearance, and the particular
drugs involved. A is incorrect because displacement does not guarantee immediate renal
excretion. B is incorrect because protein-binding interactions can occur. C is incorrect because
displacement does not permanently inactivate a drug.
Q4: A nurse is teaching a patient about a medication with a half-life of eight
hours. Assuming first-order elimination and stable pharmacokinetics,
approximately how long will it take for the amount of drug in the body to decline
to about 12.5% of its initial amount after discontinuation?
A) Eight hours
B) Sixteen hours
C) Twenty-four hours
D) Forty-eight hours
Rationale: C is correct because three half-lives reduce the amount to approximately 12.5%:
100% to 50%, then 25%, then 12.5%. A represents one half-life and B represents two. D
represents six half-lives, leaving approximately 1.56%. This calculation assumes first-order
elimination and does not account for active metabolites or other clinical factors.
Q5: A patient has been receiving a medication regularly for several weeks. The
same dose now produces a smaller response, and the patient reports no missed
doses. Which pharmacological concept best explains this finding?
A) Drug allergy
B) Pharmacological tolerance
NUR 210 EXAMS 1–4 GALEN
PHARMACOLOGY (2026) [QUESTION 1–
100] AND ANSWERS UPDATED 2026/2027 |
DETAILED RATIONALES – PRACTICE
EXAM REVIEW | INSTANT STUDY
GUIDE
Introduction
NUR 210 Pharmacology Exams 1–4 practice bank is designed to help nursing students
strengthen their understanding of pharmacological principles, medication safety, drug
classifications, therapeutic effects, adverse reactions, and clinical decision-making. It is intended
for students preparing for pharmacology assessments in a nursing program, including students
reviewing material associated with Galen College of Nursing.
Pharmacology requires more than memorizing medication names. Students must understand how
medications work, recognize potentially dangerous reactions, interpret patient assessment
findings, identify contraindications, and determine appropriate nursing interventions. These skills
are essential for safe medication administration and effective patient care.
This practice bank uses four-option multiple-choice questions, clinical scenarios, and detailed
rationales. The questions emphasize application and prioritization, including medication
calculations, pharmacokinetics, cardiovascular medications, antibiotics, endocrine drugs, and
other commonly studied medication groups. Each rationale explains the reasoning behind the
correct answer and why the alternatives are less appropriate.
Use this resource alongside your course notes, assigned textbook, and instructor-provided
objectives. The questions are original study exercises, not verified copies of Galen examination
questions, and the precise content of individual exams may vary. Consistent practice, review of
mistakes, and understanding the underlying principles can help you prepare more confidently.
Content area overview
The following is a suggested study framework for a four-exam introductory nursing
pharmacology course. Exact course coverage and question weights may differ.
1
Pharmacological foundations and medication safety
,2|Page
Suggested questions: 1–25 · Weight: 25%
Pharmacokinetics, pharmacodynamics, dosage calculations, routes, medication administration,
interactions, and safety principles.
2
Cardiovascular and renal pharmacology
Suggested questions: 26–45 · Weight: 20%
Antihypertensives, diuretics, heart failure medications, anticoagulants, and electrolyte
monitoring.
3
Anti-infective, respiratory, and immune medications
Suggested questions: 46–65 · Weight: 20%
Antibiotics, antimicrobial resistance, allergy reactions, bronchodilators, corticosteroids, and
patient education.
4
Endocrine, neurological, pain, and gastrointestinal medications
Suggested questions: 66–85 · Weight: 20%
Insulin, thyroid medications, analgesics, sedatives, seizure medications, and gastrointestinal
therapies.
5
Clinical judgment and integrated medication management
Suggested questions: 86–100 · Weight: 15%
High-alert medications, adverse reactions, prioritization, monitoring, patient teaching, and
evaluation of therapeutic outcomes.
QUESTIONS 1–100
,3|Page
Section 1: Pharmacological Foundations and Medication
Safety
Q1: A nurse administers an oral medication to a patient with significant hepatic
impairment. The medication normally undergoes extensive first-pass
metabolism. Which outcome should the nurse anticipate?
A) The medication will be completely eliminated through the lungs.
B) The medication's bioavailability may increase, potentially increasing its effects and toxicity.
C) The medication will become inactive before reaching the systemic circulation.
D) The medication will always require a higher dose to achieve a therapeutic effect.
Rationale: B is correct because impaired hepatic metabolism can reduce first-pass elimination,
allowing a greater proportion of an oral dose to reach systemic circulation. A is incorrect because
pulmonary elimination is not implied by hepatic impairment. C is incorrect because reduced
first-pass metabolism may increase, rather than eliminate, systemic drug exposure. D is incorrect
because an increased dose could worsen toxicity; dose adjustments depend on the medication,
severity of impairment, and clinical evidence.
Q2: A patient receiving a medication with a narrow therapeutic index develops
signs of toxicity despite receiving the prescribed dose. Which nursing action is
most appropriate?
A) Administer the next dose early to stabilize the drug concentration.
B) Double the next dose if the therapeutic effect is inadequate.
C) Assess the patient, review relevant laboratory results and drug levels when indicated, and
promptly notify the prescriber.
D) Independently discontinue all the patient's medications permanently.
Rationale: C is correct because a narrow therapeutic index means the difference between
therapeutic and toxic concentrations is small. Assessment, medication reconciliation, and
indicated monitoring support timely intervention. A and B can increase drug exposure and
worsen toxicity. D exceeds the usual scope of independent nursing medication management and
could cause harm; urgent withholding or discontinuation should follow applicable protocols and
clinical orders.
, 4|Page
Q3: A patient taking a medication that is highly bound to plasma proteins begins
a second medication that competes for protein-binding sites. Which statement
best describes a possible consequence?
A) The first medication must immediately be excreted unchanged.
B) Protein binding always prevents drug interactions.
C) The first medication becomes permanently inactive.
D) The unbound fraction of the first medication may temporarily increase, potentially increasing
its pharmacological effects or toxicity.
Rationale: D is correct because displacement from protein-binding sites can increase the
unbound drug fraction. The clinical effect depends on distribution, clearance, and the particular
drugs involved. A is incorrect because displacement does not guarantee immediate renal
excretion. B is incorrect because protein-binding interactions can occur. C is incorrect because
displacement does not permanently inactivate a drug.
Q4: A nurse is teaching a patient about a medication with a half-life of eight
hours. Assuming first-order elimination and stable pharmacokinetics,
approximately how long will it take for the amount of drug in the body to decline
to about 12.5% of its initial amount after discontinuation?
A) Eight hours
B) Sixteen hours
C) Twenty-four hours
D) Forty-eight hours
Rationale: C is correct because three half-lives reduce the amount to approximately 12.5%:
100% to 50%, then 25%, then 12.5%. A represents one half-life and B represents two. D
represents six half-lives, leaving approximately 1.56%. This calculation assumes first-order
elimination and does not account for active metabolites or other clinical factors.
Q5: A patient has been receiving a medication regularly for several weeks. The
same dose now produces a smaller response, and the patient reports no missed
doses. Which pharmacological concept best explains this finding?
A) Drug allergy
B) Pharmacological tolerance
